Inflammatory Factors and Their Association with Disease Severity in Patients with COVID-19

Rahmanian, Zhila; Dehghani, Khaterh; Habibi, Ehsan; Jahromi, Mohammad Sadegh Sanie; Taheri, Lohrasb; Rahmanian, Elahe; Abiri, Samaneh

[Home ] [Archive]

International Journal of Medical Investigation

Main Menu

Home

Journal Information

Articles archive

For Authors

For Reviewers

Registration

Contact us

Site Facilities

Editorial Board

Search in website

Receive site information

Volume 12, Issue 1 (3-2023)

Int J Med Invest 2023, 12(1): 59-68

Back to browse issues page

Inflammatory Factors and Their Association with Disease Severity in Patients with COVID-19

Zhila Rahmanian

, Khaterh Dehghani

, Ehsan Habibi

, Mohammad Sadegh Sanie Jahromi

, Lohrasb Taheri

, Elahe Rahmanian

, Samaneh Abiri ^*

Assistant Professor Of Emergency Medicine, Jahrom University Of Medical Sciences, Jahrom, Iran

Abstract: (640 Views)

Inflammatory factors play a very important role in causing inflammation. These inflammatory factors and proteins are the regulators of inflammatory responses. Considering the high transmission power and the pandemic caused by COVID-19, it is necessary and important to determine the effective factors in the prognosis of this disease.
Method: This study was carried out by descriptive method and based on secondary data analysis in the files of hospitalized patients with covid-19 in the first six months of 2021 by census method. The data collection tool is a checklist (data collection form). Three categories of variables including epidemiological variables, clinical variables, and laboratory variables were extracted from the patient's files and analyzed.
Results: The data of 302 patients with COVID-19 hospitalized in the ICU department of Peymaniyeh Hospital were collected. The majority of patients were over 50 years old. There was no significant relationship between the severity of the disease and all of the demographic, clinical, and laboratory variables (P>0.05), except for the number of hospitalization days that in patients with severe disease, severity was significantly higher than in patients with moderate disease severity (P=0.001); CRP, ERS, and LDH in patients with severe disease severity were significantly higher than patients with moderate disease severity (P<0.05); But there was no significant relationship between other laboratory characteristics and disease severity (P<0.05).
Conclusion: It can be concluded that patients over 50 years of age who are admitted to the ICU require more careful care and elderly patients may have a higher chance of contracting COVID-19.

Keywords: Inflammatory factors, Disease severity, Covid-19.

Full-Text [PDF 605 kb] (524 Downloads)

Type of Study: Research | Subject: General

References

1. 1. Talebi, S., Nematshahi, M., Tajabadi, A., Khosrogerdi, A. Comparison of Clinical and Epidemiological Characteristics of Deceased and Recovered Patients with COVID-19 in Sabzevar, Iran. Journal of Military Medicine, 2022; 22(6): 509-516. 2. ‏ Nikpouraghdam M, Jalali Farahani A, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. J Clin Virol. 2020 Jun;127:104378. 3. ‏Stawicki SP, Jeanmonod R, Miller AC, Paladino L, Gaieski DF, Yaffee AQ, et al. The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper. J Glob Infect Dis. 2020 May 22;12(2):47-93. 4. ‏ Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020 Aug;81(2):e16-e25. 5. Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021 Jul 26; 374:n1648. 6. ‏ Panigrahy D, Gilligan MM, Huang S, Gartung A, Cortés-Puch I, Sime PJ, et al. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev. 2020 Jun;39(2):337-340. 7. ‏ Zabetakis I, Lordan R, Norton C, Tsoupras A. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients. 2020 May 19;12(5):1466. 8. ‏ Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020 Jun;20(6):355-362. 9. ‏ Feketea GM, Vlacha V. The Diagnostic Significance of Usual Biochemical Parameters in Coronavirus Disease 19 (COVID-19): Albumin to Globulin Ratio and CRP to Albumin Ratio. Front Med (Lausanne). 2020 Nov 3;7:566591. 10. ‏ Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 2020 Nov;510:475-482. 11. ‏ Wang ZH, Shu C, Ran X, Xie CH, Zhang L. Critically Ill Patients with Coronavirus Disease 2019 in a Designated ICU: Clinical Features and Predictors for Mortality. Risk Manag Healthc Policy. 2020 Jul 20;13:833-845. 12. ‏Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis. 2020 Sep;98(1):115094. 13. Iaccarino G, Grassi G, Borghi C, Carugo S, Fallo F, Ferri C, et al. Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension. PLoS One. 2020 Oct 6;15(10):e0237297. 14. Jirak P, Mirna M, Van Almsick V, Shomanova Z, Mahringer M, Lichtenauer M, et al. Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients. Journal of Personalized Medicine. 2022 May 23;12(5):849. 15. Kautzky-Willer A, Kaleta M, Lindner SD, Leutner M, Thurner S, Klimek P. Sex differences in clinical characteristics and outcomes of patients with SARS-CoV-2-infection admitted to intensive care units in Austria. Journal of Personalized Medicine. 2022 Mar 23;12(4):517. 16. Demoule A, Morawiec E, Decavele M, Ohayon R, Malrin R, Galarza-Jimenez MA, Laveneziana P, Morelot-Panzini C, Similowski T, De Rycke Y, Gonzalez-Bermejo J. Health-related quality of life of COVID-19 two and 12 months after intensive care unit admission. Annals of Intensive Care. 2022 Feb 20; 12(1):16. 17. Gkoufa A, Maneta E, Ntoumas GN, Georgakopoulou VE, Mantelou A, Kokkoris S, et al. Elderly adults with COVID-19 admitted to intensive care unit: A narrative review. World Journal of Critical Care Medicine. 2021 Sep 9;10(5):278. 18. Martin D, Hajage D, Said L, Antoine K, Tai P, Gaëtan B, Combes A, et al. Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study. Annals of Intensive Care. 2021 May 1;11(1). 19. Ho S, Mahalingam N, Tan GP, Lew JW. Outcomes of elderly and very elderly patients admitted to intensive care unit for sepsis. 20. Armstrong RA, Kane AD, Kursumovic E, Oglesby FC, Cook TM. Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies. Anesthesia. 2021 Apr; 76(4):537-48. 21. Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, Janani M, Sepandi M. Case fatality rate of COVID-19 : a systematic review and meta-analysis. Journal of preventive medicine and hygiene. 2021 Jun; 62(2):E311. 22. Abate SM, Checkol YA, Mantefardo B. Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis. Annals of medicine and surgery. 2021 Apr 1; 64:102204. 23. Sanie Jahromi MS, Aghaei K, Taheri L, Kalani N, Hatami N, Rahmanian Z. Intensive Care Unit of COVID-19 during the Different Waves of Outbreaks in Jahrom, South of Iran. Journal of Medicinal and Chemical Sciences. 2022;5(5):734-42. 24. Kalani N, Tavasolian M, Dehghani K, Mousavi SR, Ghanbarzadeh E, Shakeri M, et al. Prognostic value of intensive care scores concerning the prediction of 30-day mortality in COVID-19 . Journal of Emergency Practice and Trauma. 2023 Jan 1; 9(1):19-24. 25. Ikram AS, Pillay S. Admission vital signs as predictors of COVID-19 mortality: a retrospective cross-sectional study. BMC Emergency Medicine. 2022 Dec; 22(1):1-0. 26. Rechtman E, Curtin P, Navarro E, Nirenberg S, Horton MK. Vital signs assessed in initial clinical encounters predict COVID-19 mortality in an NYC hospital system. Scientific reports. 2020 Dec 9; 10(1):1-6. 27. Candel BG, Duijzer R, Gaakeer MI, Ter Avest E, Sir Ö, Lameijer H, Hessels R, Reijnen R, van Zwet EW, de Jonge E, de Groot B. The association between vital signs and clinical outcomes in emergency department patients of different age categories. Emergency Medicine Journal. 2022 Dec 1; 39(12):903-11. 28. Abiri S, Mohammadizadeh M, Taheri L, Mousavi SR, Shakeri M, Rahmanian E, et al. Diagnostic Value of Blood Oxygen Saturation and C-Reactive Protein (CRP) in Predicting Lung Sequels in COVID-19 Infected Patients Admitted to Hospital: A 12-week Cohort Study. Galen Medical Journal. 2023 Feb 17; 12:e2695-. 29. Kurt C, Altunçeki̇ç Yildirim A. Contribution of erythrocyte sedimentation rate to predict disease severity and outcome in COVID-19 patients. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022 Aug 11; 2022. 30. Mardani R, Namavar M, Ghorbi E, Shoja Z, Zali F, Kaghazian H, et al. Association between serum inflammatory parameters and the disease severity in COVID‐19 patients. Journal of Clinical Laboratory Analysis. 2022 Jan; 36(1):e24162. 31. Ghahramani S, Tabrizi R, Lankarani KB, Kashani SM, Rezaei S, Zeidi N, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. European journal of medical research. 2020 Dec; 25(1):1-0.

Add your comments about this article

Mendeley

Zotero

RefWorks

Rahmanian Z, Dehghani K, Habibi E, Jahromi M S S, Taheri L, Rahmanian E et al . Inflammatory Factors and Their Association with Disease Severity in Patients with COVID-19. Int J Med Invest 2023; 12 (1) :59-68
URL: http://intjmi.com/article-1-966-en.html

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Volume 12, Issue 1 (3-2023)

Back to browse issues page

Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645